21 May 2013
Keywords: pharma, mar, et-743, bn, sales, spain, part
Article | 26 November 1999
Spain's Pharma Mar, part of the Zeltia Group, says that recent Phase IIclinical trials have demonstrated the potential of its ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 November 1999
25 November 1999
20 May 2013
© 2013 thepharmaletter.com